Nshc Derma Aesthetics Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 06-12-2024
- Paid Up Capital ₹ 1.50 M
as on 06-12-2024
- Company Age 3 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 7.39 M
as on 06-12-2024
- Revenue 152.25%
(FY 2023)
- Profit 156.55%
(FY 2023)
- Ebitda 356.72%
(FY 2023)
- Net Worth 160.38%
(FY 2023)
- Total Assets 21.89%
(FY 2023)
About Nshc Derma Aesthetics
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.50 M.
The company currently has active open charges totaling ₹7.39 M.
Urmila Nischal and Nischal Kuchangi serve as directors at the Company.
- CIN/LLPIN
U85190KA2021PTC143652
- Company No.
143652
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Feb 2021
- Date of AGM
25 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Nshc Derma Aesthetics?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Urmila Nischal  | Director | 01-Feb-2021 | Current |
| Nischal Kuchangi | Director | 01-Feb-2021 | Current |
Financial Performance of Nshc Derma Aesthetics.
Nshc Derma Aesthetics Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 152.25% increase. The company also saw a substantial improvement in profitability, with a 156.55% increase in profit. The company's net worth Soared by an impressive increase of 160.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nshc Derma Aesthetics?
Unlock access to Nshc Derma Aesthetics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Idermify Safe Skin Solutions Private LimitedActive 10 months 2 daysUrmila Nischal and Nischal Kuchangi are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 30 Aug 2023 | ₹7.39 M | Open |
How Many Employees Work at Nshc Derma Aesthetics?
Nshc Derma Aesthetics has a workforce of 0 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nshc Derma Aesthetics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nshc Derma Aesthetics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
